Continuous monitoring of proteins a game-changer for patients with rapidly deteriorating conditions

Monash University
  • A world-first discovery by Australian researchers could become a game-changer for patients at risk of rapid health deterioration, such as heart complications, stroke, sepsis and cancer.
  • Researchers developed an antibody as a biosensor, to continuously monitor rapid changes in the concentration of EGFR, a protein present on cancer cells and in body fluids.
  • Traditional diagnostic tests involve sampling something tissue, blood or other bodily fluids, and taking it to a lab
  • /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length.